Ian T. Clark - Jun 17, 2022 Form 4/A - Amendment Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ John B. Moriarty, Jr., Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Jun 17, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/27/2022, 05:13 PM
Date Of Original Report
Jun 17, 2022
Previous filing
Jun 17, 2022
Next filing
Aug 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (right to buy) Award $0 +21.5K $0.00 21.5K Jun 17, 2022 Common Stock 21.5K $3.61 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed solely for the purpose of correcting the transaction date and exercise price. The correct transaction date is "June 17, 2022" and the correct exercise price is "$3.61" as shown herein.
F2 The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 17, 2022, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.